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Introduction: We previously showed in animals that the ratio of inspired tidal volume (Vtinsp) to inspiratory peak
electrical activity of the diaphragm (EAdipk) can be used to quantify the respective patient and ventilator breath
contributions (PVBCs) during neurally adjusted ventilatory assist (NAVA). The PVBC index has not been tested
clinically.
Methods: We studied 12 intubated and mechanically ventilated patients with acute respiratory failure and
measured EAdipk, airway (Paw) and inspiratory esophageal pressure (Pes) and Vtinsp. We applied 11 different NAVA
levels, increasing them every 3 minutes in steps of 0.3 cm H2O/μV from 0 to 3.0 cmH2O/μV. At each NAVA level,
one breath was non-assisted (NAVA level 0). PVBC indices were calculated by relating Vtinsp/EAdipk of the non-assisted
breath to Vtinsp/EAdipk of the assisted breath(s) using one (
N1PVBC) or the mean value of five preceding assisted breaths
(X5PVBC). During assisted breaths, inspiratory changes in Pes (ΔPes) and transpulmonary (ΔPtp) pressures were used to
calculate the relative contribution of patient to total inspiratory lung-distending pressures (ΔPes/ΔPtp). Matching of
respiratory drive indices and squaring of the PVBC was evaluated for their effect on the correlation between PVBC and
ΔPes/ΔPtp. Linear regression analysis and Bland-Altman analysis were applied to compare indices.
Results: Using an average of five assisted breaths prior to the non-assisted breath and squaring the PVBC (X5PVBC2)
improved determination coefficients (P <0.05), adjusted the regression slope and intercept between PVBC and ΔPes/
ΔPtp toward identity (P <0.05) and reduced bias (P <0.05). Matching EAdipk between non-assisted and assisted breaths
within the range of 0.77 to 1.30 improved the relationship between X5PVBC2 and ΔPes/ΔPtp (P <0.05) and abolished
the need for EAdi normalization in the PVBC calculation (R2 = 0.96; bias = 0.16 ± 0.06; precision = 0.33 ± 0.08 (mean and
95% confidence interval)).
Conclusions: This clinical study confirms previous experimental results showing that the PVBC2 predicts the
contribution of the inspiratory muscles versus that of the ventilator during NAVA, when differences in effort (EAdi)
between non-assisted and assisted breaths are limited. PVBC could help to quantify and standardize the adjustment of
the level of assist, and hence reduce the risks of excessive ventilatory assist in patients.
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The aim of today’s approach to mechanical ventilation is
generally to achieve more spontaneous breathing and
greater use of so-called partial ventilatory assist, whereby
the ventilator and the patient share the inspiratory work.
In order for partial ventilatory assist to be efficient in pa-
tients who are spontaneously breathing, it must be syn-
chronized in terms of both its timing and its magnitude.
However, conventional modes of partial ventilatory assist
are often associated with patient–ventilator asynchrony
or dyssynchrony [1-3]. Neurally adjusted ventilatory assist
(NAVA) is a mode that uses the electrical activity of the
diaphragm (EAdi) to synchronize ventilation, and it has
been demonstrated to fulfill these requirements [4-11].
One of the biggest unknowns with the use of partial
ventilatory assist is the relative contribution of patient
effort and ventilator assistance during a breath. An index
for quantifying the respective patient and ventilator breath
contributions (PVBCs) using an experimental model of
acute respiratory failure (ARF) in animals ventilated with
NAVA was recently published [12]. In the PVBC index,
the ratio of inspiratory tidal volume (Vtinsp) and peak
inspiratory electrical activity of the diaphragm (EAdipk)
was used for both an assisted breath and a subsequent
breath with no assistance [12].
To validate the PVBC index in our previous study
[12], we measured esophageal pressure (Pes) as reflect-
ing pleural pressure and representing the patient’s
inspiratory effort. After measuring the airway pressure
(Paw) delivered by the ventilator, we calculated the trans-
pulmonary pressure (Ptp) as Paw − Pes to quantify the
total pressure applied to distend the lungs. The ratio of
inspiratory changes in Pes and Ptp (ΔPes/ΔPtp) was used
to represent the fraction/contribution of esophageal pres-
sure (patient) to total inspiratory pressure (patient + venti-
lator) during NAVA. In our previous experimental study
[12], the PVBC index was found to correlate closely to
ΔPes/ΔPtp, and it was found that squaring of the PVBC
produced a near-perfect linear relationship.
On the basis of the findings of our previous experi-
mental study, we designed the present study to evaluate
the PVBC index in humans with ARF. Similar to our
previous work in animals [12], the underlying hypothesis
was that a simple measurement of Vtinsp and EAdipk be-
tween a non-assisted breath and the preceding ventilator-
assisted breath(s) would allow the calculation of the PVBC
index in humans. We carried out the study with the
following assumptions. (1) EAdipk during an inspiration
reflects neural demand to generate Vtinsp. (2) If adding
synchronized assistance to the patient’s neural inspiratory
demand, the resulting Vtinsp depends on the sum of pa-
tient and ventilator pressure contribution. (3) If the neural
inspiratory demands are different for two consecutive
breaths, normalizing the Vtinsp to EAdipk (Vtinsp/EAdipk, inunits of l/μV), a PVBC index can be constructed using the
ratio of Vtinsp/EAdipk without ventilatory assistance to
Vtinsp/EAdipk with assistance (that is, (Vtinsp/EAdipk)no-assist/
(Vtinsp/ΔEAdipk)assist); a PVBC index close to 1 suggests
that Vtinsp is generated by the patient, whereas a PVBC
index close to 0 indicates that Vtinsp is generated by the
ventilator. (5) If the patient’s neural inspiratory demand is
similar during both non-assisted and assisted breaths, the
ratio of Vtinsp alone during the non-assisted and assisted
breaths should reflect the relative contribution of the
patient vis-à-vis patient + ventilator.
If reliable, PVBC could help to quantify and standardize
the adjustment of the level of ventilatory assistance and
reduce the risks of excessive ventilatory assistance in
patients.
Material and methods
This trial was conducted in a 30-bed general intensive care
unit (ICU) of a teaching hospital affiliated with Southeast
University in China. The protocol was approved by the
Institutional Ethics Committee of Zhongda Hospital
(approval number 2010ZDLL018.0), and informed consent
was obtained from the patients or their next of kin. The
trial is registered at ClinicalTrials.gov (NCT01663480).
Patients
Patients were eligible for inclusion if they were (1) intu-
bated or tracheotomized, (2) undergoing assisted mechan-
ical ventilation, (3) considered (by the attending physician)
to be able to tolerate a short period of spontaneous
breathing (not having passed spontaneous breathing trial
prior to study) and (4) awake.
The exclusion criteria were (1) age <18 years; (2) his-
tory of esophageal varices; (3) gastroesophageal surgery
in the previous 12 months or gastroesophageal bleeding
in the previous 30 days; (4) coagulation disorders (inter-
national normalized ratio >1.5 and activated partial
thromboplastin time >44 seconds); (5) history of acute
central or peripheral nervous system disorder or severe
neuromuscular disease; (6) history of leukemia, severe
chronic liver disease, solid organ transplantation, malig-
nant tumor (because of their immunocompromised state
and increased risk of infection); or (7) severe cardiac dis-
ease (to avoid provocation of hemodynamic instability).
Measurements
Patients were ventilated with a SERVO-i ventilator (Maquet,
Solna, Sweden). A nasogastric feeding tube (NeuroVent
Research, Toronto, ON, Canada) with electrodes to meas-
ure EAdi and balloons to measure esophageal pressure
(Pes) and gastric pressure (Pga) were inserted through the
nose. After verifying the correct positioning of the esopha-
geal balloon by an occlusion test with spontaneous breaths
[13], and after accurate positioning was confirmed by
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tilator (according to the manufacturer’s recommenda-
tions), the nasogastric tube was secured. Flow and Paw
measurements were acquired from the SERVO-i ventila-
tor, and Pes and Pga levels were acquired via pressure
transducers (NeuroVent Research).
Throughout the protocol, EAdi, Paw, flow, Pes and
Pga waveforms were recorded by using a custom-made
system (NeuroVent Research) for offline analysis. EAdi,
Paw, flow and tidal volume (Vt) were acquired from the
SERVO-i ventilator via the RS232 serial port at a sam-
pling rate of 100 Hz. Pes and Pga were acquired at 2
KHz using via a DT 304 A/D board (data translation)
and synchronized to the RS232 serial port signals at
100 Hz. Ptp was calculated as Paw − Pes.
Study protocol
Patients were receiving intravenous analgesia with mor-
phine at 1 to 2 mg/hr, and no sedative was used during
the experimental period. Patients were ventilated in
pressure support mode (set by the attending physician)
for 30 minutes after the nasogastric tube insertion. Pa-
tients were then switched to NAVA, with the NAVA level
initially set to 0 for 3 minutes. Positive end-expiratory
pressure (PEEP) and fraction of inspired oxygen (FiO2)
were set as prescribed by the attending physician. The
NAVA level was then increased every 3 minutes in steps
of 0.3 cmH2O/μV to a NAVA level of at least 3.0 cmH2O/
μV. The upper pressure limit was set to 45 cmH2O in
order not to interfere with the titration. At each NAVA
level, one non-assisted breath was obtained by reducing
the NAVA level to 0 (hereafter NAVA zero breath). PEEP
was unchanged during these breaths. At every NAVA
level, one inspiratory occlusion was performed to measure
neuromechanical efficiency (NME), as described below.
Offline signal processing
At each NAVA level, the last five breaths (prior to the
NAVA zero breath) were analyzed. Figure 1 illustrates
measurement points for signal processing. Neural in-
spiratory time (Ti) was defined as the time between the
onset of increasing EAdi and the point where EAdi
dropped to 70% of its peak. Although EAdipk could be
suggested as the end of Ti, the EAdi drop to 70% of its
peak was the off-cycling criterion for NAVA and thus
allowed Ti to include detection of peak pressures and
integration of inspiratory volume throughout the entire
assist cycle (Figure 1). During each breath’s Ti period,
EAdipk) and peak airway pressure (Pawpk) were calcu-
lated. As well, ΔPes and ΔPtp between the onset of EAdi
to their respective peak values were calculated. Note that
the Pes signal has a negative trajectory and negative
peak. Note also that peak values were obtained anytime
during Ti and were not exactly matched in time.Mean values for changes in EAdi and Pes were also
calculated for each Ti period. Mean EAdi was obtained
by integration during the Ti period and then divided by
Ti. Mean Pes and Ptp were calculated the same way;
however, values used during Ti integration were sub-
tracted by the values measured at onset each of Ti. The
mean and peak values for EAdi, ΔPes, Paw and ΔPtp
were closely related (range of R2 = 0.94 to 0.97), and, for
this reason, mean values are not reported. Of note, the
mean values represented 60% to 70% of the peak values.
Breathing frequency (Fb) was calculated on a breath-
by-breath basis as 60 divided by total breath time (that
is, time between consecutive onsets of EAdi).
In order to quantify presence of paradoxical expiratory
muscle relaxation during the neural inspiration, we cal-
culated the change in Pga (ΔPgaparadox) between onset of
EAdi and the lowest value observed during Ti for the
assisted breath(s) preceding the non-assisted breath.
NME was calculated as Pawpk/EAdipk during inspira-
tory occlusions at each NAVA level [14]. This index pro-
vides information about inspiratory muscle contractility
and whether NME could be affected by the protocol
(for example, by dynamic hyperinflation).
Main analysis
PVBC was calculated as (Vtinsp/EAdipk)no-assist/(Vtinsp/
EAdipk)assist. Another index, PVBC
2, was calculated, sim-
ply by squaring PVBC [12]. Previous experimental work
[12] showed that squaring PVBC was useful as a correc-
tion to improve its relationship to ΔPes/ΔPtp.
ΔPes/ΔPtp (sign was reversed to obtain positive index
value) was used as a direct index to quantify the patient
inspiratory muscle effort (ΔPes) contribution to total
lung-distending pressure (ΔPtp) during assisted breaths
[12]. As the assist (Paw) increases, the patient’s mechan-
ical inspiratory effort (ΔPes) decreases (that is, becomes
less negative), thus reducing its fraction relative to the
total inspiratory effort ΔPtp (Ptp = Paw − Pes), indicating
the relative contribution of patient inspiratory pressure
and total inspiratory pressure.
In our previous study using the experimental animal
model, both PVBC and PVBC2 were related to ΔPes/ΔPtp
[12] during increasing NAVA levels. In the animal study,
respiratory drive (and its response) was fairly uniform.
However, in non-sedated humans, intrabreath variability is
often higher. In addition, we studied a heterogeneous
group with a wide range of EAdi values at zero NAVA
level. For this reason, we evaluated methods of refining
the accuracy and stability of the PVBC and PVBC2 indices
as described in the subsections below.
Single versus averaged breaths
We calculated the PVBC and PVBC2 indices in two ways:
(1) using the same method described previously [12],
Figure 1 Description of reference points used for calculation of respiratory variables. Reference points are indicated for calculating peak
airway pressure (Pawpk), change in esophageal pressure (Pes) from onset of electrical activity of the diaphragm (EAdi) to peak (nadir) (ΔPes),
change in transpulmonary pressure (Ptp) from onset of EAdi to peak (ΔPtp), peak EAdi (EAdipk) and inspiratory tidal volume (Vtinsp). Neural
inspiratory period (Ti) and total breath time (Ttot) are indicated at bottom. Breathing frequency (Fb) was calculated as 60/Ttot.
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the previous single breath (referred to as N1PVBC and
N1PVBC2); and (2) using PVBC and PVBC2 calculated
with five averaged EAdi values from the five preceding
breaths (“X5”) (referred to as X5PBVC and X5PBVC2).
Matching respiratory drive between assisted and
non-assisted breaths
Respiratory drive can be interpreted from both EAdipk
and Ti. As mentioned in the Introduction above, to cal-
culate the PVBC-related indices, we assumed that either
respiratory drive should be fairly similar for the
unassisted and the assisted breaths or breaths could be
corrected by using respiratory drive to “normalize” Vtinsp
[12]. To evaluate the effect of “matching” the respiratory
drive for unassisted and assisted breaths on the relation-
ship between PVBC and ΔPes/ΔPtp, we tested different
criteria and/or filters. We calculated the ratio between
EAdipk with and without assist (EAdipk,no-assist/EAdipk,assist)
as well as Ti with and without assist (Tino-assist/Tiassist) at
each NAVA level. Assuming that a ratio of 1 was a per-
fect match, we arbitrarily decided upon five ranges that
successively reduced the degrees of freedom for either
EAdipk,no-assist/EAdipk,assist or Tino-assist/Tiassist: 0.63 to
1.60, 0.67 to 1.50, 0.71 to 1.40, 0.77 to 1.30 and 0.83 to
1.20. Each range was selected to show the same relative
changes above and below 1.0. We also tested if closely
matched EAdipk values between non-assisted and assisted
breaths could eliminate the need for EAdi normalization
in the PVBC indices. For this purpose, we calculated
PVBC simply as the ratio between Vtinsp for non-assisted
to assisted breaths (Vtinsp,no-assist/Vtinsp,assist), subsequently
referred to as PVBCβ (using same annotations as the
PVBC).Table 1 Patient descriptionsa
Patient Age, yr Sex APACHE II score Predicted weight, kg
1 58 F 12 65
2 60 F 22 65
3 32 F 16 52
4 82 M 32 70
5 72 F 30 52
6 38 M 18 75
7 69 F 24 60
8 81 F 30 64
9 57 F 20 50
10 76 F 28 50
11 56 M 16 67
12 60 F 28 58
Mean (SD) 61.8 (15.6) 23.0 (6.6) 60.7 (8.0)
aAPACHE II, Acute Physiology and Chronic Health Evaluation II; FiO2, Fraction of insp
SpO2, Pulse oxygen saturation.Statistical analysis
Statistical analysis was performed with SigmaPlot 12.5
(Systat Software, San Jose, CA, USA). Values in the text
and figures are mean ± 95% confidence interval, unless
otherwise indicated.
The relationship between different variables was tested
with linear regression analysis. To identify the impact of
averaging and breath matching on R2-values for the
PVBC–ΔPes/ΔPtp relationship, one-way repeated-measures
analysis of variance was performed. Post hoc comparison
was performed by using the Student–Newman–Keuls test.
A significant difference was defined as P <0.05. Bland-
Altman analysis was used to study agreement between
methods.
Results
As shown in Table 1, 12 patients (3 males; age range, 38
to 82 years; predicted body weight range, 51 to 66.5 kg)
were studied (9 patients with pneumonia, 2 patients with
cardiogenic pulmonary edema and 1 patient with acute
respiratory distress syndrome). All patients were receiv-
ing supplemental oxygen (FiO2 = 0.4 or 0.5), with oxygen
saturation ranging from 95% to 100%.
All subjects reached a NAVA level of 3.0 cmH2O/μV.
Group mean values for ΔPgaparadox, the largest magni-
tude of paradoxical expiratory muscle relaxations during
Ti, were −0.08 (0.06) and −0.08 (0.05) cmH2O during
the single and five assisted breaths (preceding the non-
assisted breaths), respectively.
Figure 2 exemplifies, in one patient, the effect of in-
creasing NAVA level on Pawpk, EAdipk, ΔPes and Vtinsp
(Figure 2A). It also provides examples of time tracings
for Paw, EAdi, Vt and Pes for five assisted breaths and
one unassisted breath (yellow vertical shadow) at oneCause of respiratory failure PEEP, cmH2O FiO2 SpO2
Cardiogenic pulmonary edema 8 0.4 95
Cardiogenic pulmonary edema 6 0.4 98
Pneumonia 8 0.4 95
ARDS, intestinal infection 4 0.4 99
Pneumonia 5 0.4 98
Pneumonia 8 0.5 95
Pneumonia 5 0.4 100
Pneumonia 7 0.4 98
Pneumonia 4 0.4 98
Pneumonia 5 0.4 100
Pneumonia 5 0.4 100
Pneumonia 5 0.4 96
5.8 (1.5) 0.41 (0.02) 98 (2)
ired oxygen; PEEP, Positive end-expiratory pressure; SD, Standard deviation;
Figure 2 Example of neurally adjusted ventilatory assist level titration in one patient. (A) Effect of 11 increases of the neurally adjusted
ventilatory assist (NAVA) level in steps of 0.3 cmH2O/μV (x-axis) on peak airway pressure (Pawpk), peak inspiratory electrical activity of the
diaphragm (EAdipk), tidal volume (Vtinsp) during assisted (closed circles) and non-assisted (open circles) breaths and esophageal pressure peak
inspiratory change from onset of EAdi (ΔPes). (B) and (C) Respective raw signals for Paw, EAdi, volume and Pes for five assisted and one unassisted
breath (NAVA zero breath is indicated by yellow vertical bars) at a low NAVA level (B, red tracings), which relates to the red dot in (A), and at high
NAVA level (C, green tracings), which relates to the green dot in (A).
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the total of eleven applied.
The NME did not change significantly from NAVA level
zero (NME = 1.40 ± 0.63 cmH2O/μV) to the last titration
step at NAVA level 3.0 cm H2O/μV (NME= 1.70 ± 0.86
cmH2O/μV).
Figure 3 shows how averaging five assisted breaths
(closed symbols, “X5” notation) versus using one non-
assisted breath (open symbols, “N1” notation) prior to
the non-assisted breath influences the PVBC indices’
correlation to ΔPes/ΔPtp. It also shows the impact of
respiratory drive “matching” for both EAdipk,no-assist/
EAdipk,assist (orange symbols) and Tino-assist/Tiassist (blue
symbols) on the determination coefficients (R2, y-axes)
between PVBC indices and ΔPes/ΔPtp. PVBC versus
ΔPes/ΔPtp showed higher determination coefficients
(y-axes) when calculated from the average of fivepreceding assisted breaths compared with when they
were calculated with one assisted breath. Better matching
of EAdipk,no-assist/EAdipk,assist increased determination co-
efficients for PVBC indices with five breaths average, reach-
ing significance with matching criteria (EAdipk,no-assist/
EAdipk,assist) at 0.77 to 1.30.
Improved matching of Ti (x-axes in Figure 3) did not
improve determination coefficients (y-axes in Figure 3)
between PVBC indices and ΔPes/ΔPtp. We found that
the EAdipk,no-assist/EAdipk,assist of 0.77 to 1.30 provided
the best combination of highest R2 values, lowest variabil-
ity and least exclusion of data points not meeting match-
ing criteria. In summary, this analysis showed the highest
determination coefficients between the PVBC indices and
ΔPes/ΔPtp when the PVBC was calculated using an aver-
age of five assisted breaths with EAdipk,no-assist/EAdipk,assist
within the 0.77 to 1.30 range. The distribution of
Figure 3 Impact of breath averaging and breath matching on coefficient of determination between patient-ventilator breath contribution
indices and ratio of inspiratory changes in esophageal pressure and transpulmonary pressure. Left: Coefficient of determination (R2) between
patient-ventilator breath contribution (PVBC) and ratio of inspiratory changes in esophageal pressure and transpulmonary pressure (ΔPes/ΔPtp) (y-axis)
is plotted against different matching criteria of increasingly strict inclusion levels (x-axis). Data are presented for PVBC indices when PVBC is calculated
with one assisted breath (N1PVBC, open symbols) or with five assisted breaths averaged (X5PVBC, closed symbols). The determination coefficient was
found to improve for X5PVBC at matching levels for ratios of inspiratory peak electrical activity of the diaphragm (EAdipk) with versus without assist
(EAdipk,no-assist/EAdipk,assist) ranging from 0.77 to 1.30 ($P <0.05, orange closed symbols) and to become significantly higher than
N1PVBC (*P <0.05).
Increasing the matching of the neural inspiratory time (Ti) between assisted and non-assisted breaths (Tino-assist/Tiassist, blue symbols) did not result in
any improvement in R2. Values are presented as mean with 95% confidence interval. Right: Same as left graph, but for PVBC2. The R2-value between
PVBC2 and ΔPes/ΔPtp (y-axis) is plotted when PVBC2 is calculated with one assisted breath (N1PVBC2, open symbols) or with five assisted breaths
averaged (X5PVBC2, closed symbols) and when different matching criteria are used of increasingly strict inclusion levels (x-axis). The determination
coefficient was found to improve for X5PVBC2 at matching levels for EAdipk,no-assist/EAdipk,assist of 0.77 to 1.30 ($P <0.05, *P <0.05, orange closed symbols)
and to become significantly higher than N1PVBC2 (*P <0.05). Increasing the matching of the Ti between assisted and non-assisted breaths (Tino-assist/Tiassist,
blue symbols) did not result in any improvement in R2. Values are presented as mean with 95% confidence interval.
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levels is presented in Figure 4.
Henceforth, results are reported only for patients with
EAdipk,no-assist/EAdipk,assist ratios between 0.77 and 1.30.
Figure 5 shows group mean values for ΔPes, Pawpk
(including PEEP), ΔPtp (including PEEP), PEEP, EAdipk,
Vtinsp, and Fb for increasing NAVA levels. With progres-
sive increases in NAVA level, there was a concomitant
reduction in EAdipk until a point where the increase in
Vt plateaued. Fb did not change for the titration of
NAVA levels.
Figure 6A illustrates the group mean values for
X5PVBC, X5PVBC2 and ΔPes/ΔPtp with increasing
NAVA levels. Figures 6B and C show ΔPes/ΔPtp (x-axes)
plotted against X5PVBC and X5PVBC2 (y-axes), respect-
ively. Figure 6D shows the same information as Figure 6A,
but with PVBC calculated without normalizing Vtinsp by
EAdipk (referred to as
X5PVBCβ and X5PVBCβ2). Theproportionality between X5PVBCβ versus ΔPes/ΔPtp as
well as X5PVBCβ2 versus ΔPes/ΔPtp is demonstrated in
Figure 6E and F.
As the NAVA level increased, X5PVBC and X5PVBC2
as well as X5PVBCβ and X5PVBCβ2 (panels A and D)
decreased in a fashion similar to that of ΔPes/ΔPtp,
showing less contribution by the patient. Squaring the
indices significantly adjusted the regression coefficients
and moved the intercepts for X5PVBC2 (panel C) and
X5PVBCβ2 (panel F) closer to zero.
Table 2 shows group mean values for bias, standard
deviation, lower and upper levels of agreement and
precision of the Bland and Altman analysis for X5PVBC,
X5PVBC2, X5PVBCβ and X5PVBCβ2 indices versus ΔPes/
ΔPtp. Squared indices, X5PVBC2 and X5PVBCβ2, reduced
bias (P <0.05), and better agreement for lower (P <0.05)
and upper (P <0.05) levels of adjustment with regards to
ΔPes/ΔPtp. All data in Figure 6 and Table 2 use the
Figure 4 Distribution of ratios between peak inspiratory electrical activity of the diaphragm without assist to peak inspiratory
electrical activity of the diaphragm with assist. Histograms showing distribution of all electrical activity of the diaphragm (EAdi) matching
index values (EAdipk,no-assist/EAdipk,assist) when calculated using a single assisted breath (left) or using the average of five breaths preceding the
non-assisted breath (right). Of all the breaths, 78% fell between 0.77 and 1.30.
Figure 5 Group mean values of measured variables during neurally adjusted ventilatory assist level titration. Leftmost panel: Mean and
95% confidence interval values (y-axis) for peak inspiratory change in esophageal pressure from onset of electrical activity of the diaphragm
(ΔPes, open blue circles), applied positive end-expiratory pressure (PEEP, open green squares), peak airway pressure (Pawpk, green solid squares),
peak inspiratory change in transpulmonary pressure from onset of electrical activity of the diaphragm (ΔPtp, blue solid circles) above PEEP, as the
neurally adjusted ventilatory assist (NAVA) level was increased from 0 to 3.0 cmH2O/μV (x-axis). Next three panels to the right: Mean and 95% confidence
interval values plotted for peak electrical activity of the diaphragm (EAdipk), inspiratory tidal volume (Vtinsp) for assisted (closed symbols) and
non-assisted breaths (open symbols) and breathing frequency (Fb) during increasing NAVA levels.
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Figure 6 Relationship between patient-ventilator breath contribution indices and ratio of inspiratory changes in esophageal and
transpulmonary pressure indices with and without electrical activity of the diaphragm normalization. (A) Group mean values and 95%
confidence interval for indices of patient-ventilator breath contribution calculated from single non-assisted breath compared with five averaged
electrical activity of the diaphragm (EADi) values from the five preceding breaths (X5PVBC), X5PVBC2 and ratio of inspiratory changes in esophageal
and transpulmonary pressure (ΔPes/ΔPtp) with increasing neurally adjusted ventilatory assist (NAVA) levels. (B) and (C) X5PVBC and X5PVBC2
plotted against ΔPes/ΔPtp, respectively. Note how X5PVBC2 corrected the regression slope against ΔPes/ΔPtp. (D) Group mean values and 95%
confidence intervals for X5(PVBCβ), X5(PVBCβ)2 and ΔPes/ΔPtp indices with increasing NAVA levels. (E) and (F) X5(PVBCβ) and X5(PVBCβ)2 plotted
against ΔPes/ΔPtp, respectively. Note how X5PVBCβ2 corrected the regression slope against ΔPes/ΔPtp. All values were calculated with the
five-breath averaging technique and EAdi matching criteria (EAdipk,no-assist/EAdipk,assist) of 0.77 to 1.30.
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gle non-assisted breath and mean of previous 5 breaths.
Discussion
The results of the present study validate a clinical index
that can be used to quantify the relative inspiratory ef-
fort of a patient during assisted ventilation. Comparison
of Vtinsp corrected for neural inspiratory drive for a non-
assisted breath (Vtinsp/EAdipk)no-assist to that during an
assisted breath (that is, (Vtinsp/EAdipk)assist) resulted in aTable 2 Bland-Altman analysis for X5PVBC, X5PVBC2, X5PVBCβ
X5PVBC X5PVBC2
Mean 95% CI Mean 95%
Bias 0.34 0.05 0.16* 0.06
SD 0.10 0.01 0.10 0.02
Lower LoA 0.16 0.07 −0.04* 0.09
Upper LoA 0.56 0.07 0.35* 0.04
Precision 0.40 0.06 0.39 0.07
aCI, Confidence interval; LoA, Level of adjustment; ΔPes/ΔPtp, Ratio of inspiratory ch
breath contribution as ratio of inspiratory tidal volume for non-assisted to assisted
non-assisted breath compared with five averaged electrical activity of the diaphrag
versus X5PVBC and X5PVBCβ.PVBC index that closely reflected the ratio between pa-
tient (ΔPes) and total (patient + ventilator =ΔPtp) mech-
anical inspiratory effort. We also demonstrate that
selection of non-assisted and assisted breaths with well-
matched neural efforts improved the reliability of the
PVBC index. Computation using an average of the five
preceding assisted breaths, squaring PVBC and including
only breaths with EAdi ratios for non-assisted and
assisted breaths between 0.8 and 1.3 resulted in the most
reliable PVBC (X5PVBC2) index. Using EAdi to matchand X5PVBCβ2 with reference to ΔPes/ΔPtpa
X5PVBCβ X5PVBCβ2
CI Mean 95% CI Mean 95% CI
0.33 0.05 0.16* 0.06
0.09 0.02 0.08 0.02
0.16 0.07 −0.01* 0.08
0.50 0.06 0.32* 0.06
0.34 0.07 0.33 0.08
anges in esophageal and transpulmonary pressure; PVBCβ, Patient-ventilator
breaths; X5PBVC, Patient-ventilator breath contribution calculated from single
m values from the five preceding breaths; SD, Standard deviation. *P <0.05
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correct for changes in neural respiratory drive and
allowed computation of PVBC based on inspiratory
volume alone.
The results of our clinical study of patients with ARF
generally confirm those of the previous study in animals
by Grasselli et al. [12]. We found that the coefficient of
determination (R2) between PVBC indices and ΔPes/ΔPtp
improved when neural inspiratory drive was matched be-
tween assisted and non-assisted breaths. Neural drive can
be considered to have two major components: (1) neural
breathing frequency (that is, the periodic repetition of
neural activation, which is a temporal indicator of neural
respiratory drive) and (2) amplitude (that is, the magni-
tude of neural respiratory drive). Our finding that match-
ing assisted and non-assisted breaths for Ti had little
effect on R2 between PVBC and ΔPes/ΔPtp suggests that
temporal variability in neural drive had little influence on
the accuracy of the PVBC index. However, EAdipk had a
strong impact in improving the fit between PVBC and
ΔPes/ΔPtp, suggesting that the magnitude of neural
inspiratory effort is important for the accuracy of the
PVBC index.
Transesophageal measurements of EAdi mainly repre-
sent motor unit activation for a portion of the crural
diaphragm. Despite this, studies have demonstrated that
the EAdi provides a good measure of the global dia-
phragm activation in healthy subjects [15] and mechan-
ically ventilated patients with ARF [16]. Nonetheless,
changes in respiratory muscle recruitment may cause al-
terations of chest wall configuration that would change
NME between assisted and non-assisted breaths [15-17].
In the present study, the NME obtained during the oc-
clusions was not affected by increasing NAVA levels.
The present study demonstrates a better fit to the re-
gression line (higher R2 values) between PVBC and
ΔPes/ΔPtp when an average of five assisted breaths was
used compared with a single breath. We did not apply
this approach for the non-assisted breaths because of
clinical concerns about removing the assist for several
breaths and the potential of altering respiratory muscle
recruitment for the various breaths.
Grasselli et al. [12] showed that squaring PVBC values
linearized the regression slope obtained with ΔPes/ΔPtp
with changes in NAVA levels, and it also moved the
intercept closer to zero. Our findings were similar,
although they were not as evident. Squaring X5PVBC
altered the regression slope and moved the intercept
closer to zero compared with X5PVBC; however, there
was no group mean increase of improved fit to the re-
gression line between PVBC and ΔPes/ΔPtp as would be
expected if curvilinearity had been removed. Yet again,
this could be due to the wide heterogeneity in physio-
logical and pathological factors between patients.Our finding that a ratio of EAdi between assisted and
non-assisted breaths of 0.78 to 1.30 produced equally
good fit to ΔPes/ΔPtp when we calculated X5PVBCβ2
from “only” the ratio of Vtinsp from unassisted to assisted
breaths (that is, without normalizing to EAdi) confirms
our initial hypothesis that when inspiratory effort is
matched between assisted and non-assisted breaths,
Vtinsp must change if synchronized assist is added or re-
moved. Hence, the ratio of Vtinsp values for non-assisted
and assisted breaths should be close to a value of 1 when
no assist is being provided (the patient generates all the
volume) and near zero when a breath is fully assumed
by the ventilator.
Critique of methods
The results given in the present study relate to peak
values (that is, changes in amplitude in the signal be-
tween the onset of EAdi and the peak of a signal). Re-
garding Paw, one could argue that because NAVA does
not have a plateau pressure, peak and mean values
would provide different information. Regression analysis
indicated extremely high correlation between the peak
and mean values for Paw. Similarly, other variables, such
as ΔPes, ΔPtp and EAdipk, showed extremely strong re-
lationships to their respective mean values. Given that
pressures and EAdi are presented as peak values on the
ventilator, we preferred to present results that had the
closest relationship to clinical implementation.
In spontaneously breathing patients recovering from
acute respiratory failure, expiratory muscle contraction
during expiration followed by expiratory muscle relax-
ation during the ensuing inspiration may invalidate and
amplify the decrease in esophageal pressure [18]. Such
an overestimation of ΔPes can be detected by an end-
expiratory decrease in Pga causing a concomitant de-
crease in Pes that is not related to inspiratory muscle
effort [19]. In the present study, we used onset of EAdi as
the starting point to calculate ΔPes, which ensured that
diaphragm contraction had started and eliminated the
possibility for preinspiratory overestimation of the ΔPes.
Our quantification of paradoxical expiratory muscle re-
laxation during neural inspiration as ΔPgaparadox, calcu-
lated as the change in Pga between onset of EAdi and
the lowest value observed during Ti for the assisted
breath(s) preceding the non-assisted breath, was minis-
cule. The latter shows that end-expiratory expiratory
muscle relaxation was not an important contributor to
our results.
As depicted in Figure 6, both X5PVBC2 and X5PVBCβ2
showed values about 0.1 relative units higher than ΔPes/
ΔPtp. One reason for higher PVBC indices was that
ΔPes decreases more than EAdi during assisted breaths.
In fact, EAdipk does not reach zero when ΔPes indicates
100% unloading [20]. This means that for a given EAdipk,
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assisted breaths [12]. Moreover, at a NAVA level of zero,
the assist is not a true “zero assist,” because the SERVO-i
ventilator still delivers a pressure of 2 cmH2O. These fac-
tors would act to shift PVBC indices upward.
Relaxation of the chest wall or expiratory muscle re-
cruitment prior to EAdi off-cycling opens the expiratory
valve during assisted breaths. This is due to the increase
in Pawpk by 3 cmH2O above target, causing a pressure
off-cycling algorithm to be activated. If this happens, the
Pawpk is somewhat (3 cmH2O) higher than expected and
the ΔPes/ΔPtp ratio would be lower than expected, es-
pecially at the lowest NAVA levels. Another reason that
the ΔPes/ΔPtp ratio was less than 1.0 at the lowest
NAVA level could be that Paw was lost because the
endotracheal tube resistance led to overestimation of the
Paw used to calculate Ptp.
Our finding of a 16% bias with the Bland-Altman ana-
lysis probably relates to a combination of overestimating
PVBC as well as underestimating ΔPes/ΔPtp.
A limitation of this study’s design is that we did only
one “PVBC maneuver” (NAVA zero breath) per NAVA
level. Consequently, if the breath without assist failed to
meet the inclusion criteria for EAdipk or Ti matching,
we would lose the PVBC calculation for that NAVA
level. If applied as an automatic function for use in the
clinic, the non-assisted breaths could be repeated inter-
mittently to increase the likelihood of obtaining accept-
able and reproducible PVBC values.
Breathing patterns are affected by many factors, and
stable activation and rhythm require a low level of dis-
turbance. The protocol of the present study was per-
formed by manual interventions by the investigators at
the bedside, which could have distracted the patients
compared with a system with built-in algorithms for
non-assisted breaths and occlusions.
Three minutes at each NAVA level could be consid-
ered short; however, our data indicate that this was suffi-
cient to produce clear reductions in both ΔPes and
EAdipk for each NAVA level. Viale and colleagues
showed that about five breaths were sufficient for pa-
tients to adapt and adjust to the new assist level during
pressure support ventilation [21]. In the present study,
we therefore focused on relatively quick unloading ra-
ther than on the effects of CO2 and pH on respiratory
drive. To the contrary, our data showing that 78% of the
breaths fell within the 0.77 to 1.30 matching criteria
(one breath to the next) strongly suggest that the first
unassisted breath is affected little by removal of ventila-
tory assist.
Clinical relevance
In previous clinical studies, researchers have reported,
on average, EAdipk values of about 10 μV when theNAVA level was adjusted to match Pawpk during pres-
sure support, providing clinically acceptable Vt levels
[5,22,23]. (Note that although the absolute value of EAdi
can be influenced by anatomical differences, this average
value is representative of published data obtained from
over 560 patients.) According to the results of the
present study, this corresponds to average X5PVBC2 and
X5PVBCβ2 indices of about 0.5 (that is, indicating the
patient’s contribution is about half the total effort). It is
interesting to observe that at an EAdi of 10 μV, the ΔPes
was about −5 cmH2O, which could be considered a
normal workload. As demonstrated previously during
synchronized assist with NAVA, breathing frequency
provided little information about acute changes in re-
spiratory load and drive. As depicted in Figure 5, the ini-
tial increase in Paw and ΔPtp decreased at NAVA levels
of 1.5 to 1.8. It has been hypothesized that the onset of
this plateau indicates that the patient is “satisfied” by the
assist [24]. In the present study, this occurred at an aver-
age EAdi of 7 to 8 μV, with X5PVBC2 and X5PVBCβ2
indices of about 0.3 to 0.4 (that is, when the patient’s
contribution was about one-third of total effort). Al-
though the highest precision of 0.3 (Bland-Altman ana-
lysis) obtained with X5PVBCβ2 could be considered
somewhat low, targeting X5PVBCβ2 of 0.5 while moni-
toring EAdi with a target 10 μV would likely improve
the ability to control patient unloading. This type of
monitoring would have a direct impact on how to set
the ventilator’s assist and, perhaps more important,
would provide clinical studies aimed at ensuring avoid-
ance of overassist and optimizing assist for faster
weaning. In the present study, PVBC analysis was done
by neurally synchronized and proportional assist. Princi-
pally, the comparison of Vtinsp for assisted and non-
assisted breaths of similar EAdi amplitude should also
work with pressure support ventilation; however, future
studies are required.
Conclusions
The present study demonstrates a clinical index used to
quantify the relative inspiratory effort of a patient during
assisted ventilation. Computation of PVBC as a ratio of
Vt values from one non-assisted breath to the average of
five preceding assisted breaths, squaring PVBC and
including only breaths with EAdipk whose ratio between
non-assisted and assisted breaths is within the range of
0.77 to 1.30 results in a clinically useful PVBC index.
Key messages
 The ratio of inspired tidal volume (Vtinsp) and
inspiratory peak electrical activity of the diaphragm
(EAdipk) between non-assisted and assisted breaths,
defined as patient and ventilator breath
Liu et al. Critical Care  (2015) 19:43 Page 12 of 13contributions (PVBCs), can be used to predict the
relative contribution of the inspiratory muscles
versus that of the ventilator during neurally adjusted
ventilatory assist (NAVA).
 Computation of PVBC as a ratio of tidal volumes
from one non-assisted breath to the average of five
preceding assisted breaths, squaring PVBC and
including only breaths with EAdipk whose ratio
between non-assisted and assisted breaths is within
the range of 0.77 to 1.30 resulted in a clinically
useful PVBC index.Abbreviations
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